Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
2
HQ
Bnei Brak
Sector
Health Tech & Life Sciences
About
CannaMore is a preclinical- and clinical-stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide.
The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases.
CannaMore is a portfolio company of BioSeedXL.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcareLaboratories
Business model
B2B
Tags
pharmaceuticalsbiopharmaceuticaltreatmentsinflammatory-diseasesmedical-cannabispharma-companies